Lilly produces medicines that meet patients’ health care needs. It is critical that patients have access to our products which improve or, more importantly, save lives. As global debates continue regarding health care and pharmaceutical innovation, we’re committed to participating in the public policy process as a responsible corporate citizen.
Lilly considers stakeholder input and a variety of other factors in determining which issues are most relevant for engagement. These factors include patient needs, business strategy, public policy dialogue, and legislative debate.